Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis

22Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rifapentine is highly protein bound in blood, but the free, unbound drug is the microbiologically active fraction. In this exploratory study, we characterized the free plasma fraction of rifapentine in 41 patients with tuberculosis. We found a lower total rifapentine concentration but significantly higher free rifapentine levels in African patients of black race compared to non-Africans. These data support larger pharmacokinetic/pharmacodynamic studies to confirm these findings and assess free rifapentine in relation to microbiological and clinical outcomes. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Egelund, E. F., Weiner, M., Singh, R. P., Prihoda, T. J., Gelfond, J. A. L., Derendorf, H., … Peloquin, C. A. (2014). Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis. Antimicrobial Agents and Chemotherapy, 58(8), 4904–4910. https://doi.org/10.1128/AAC.01730-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free